Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Prescient Therapeutics, Ltd.
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Icahn School of Medicine at Mount Sinai
Stanford University
City of Hope Medical Center